427 related articles for article (PubMed ID: 18255279)
1. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.
Li XR; Ji F; Ouyang J; Wu W; Qian LY; Yang KY
Eur J Surg Oncol; 2006 Dec; 32(10):1130-4. PubMed ID: 16806792
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
7. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
[TBL] [Abstract][Full Text] [Related]
11. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
12. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].
Yuan Z; Fan J; Wu ZQ; Zhou J; Qiu SJ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1256-9. PubMed ID: 17686260
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma.
Zhang HK; Pan K; Wang H; Weng DS; Song HF; Zhou J; Huang W; Li JJ; Chen MS; Xia JC
Cancer Lett; 2008 Mar; 261(2):183-92. PubMed ID: 18160212
[TBL] [Abstract][Full Text] [Related]
14. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
[TBL] [Abstract][Full Text] [Related]
15. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
[TBL] [Abstract][Full Text] [Related]
16. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
[TBL] [Abstract][Full Text] [Related]
17. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma.
Liu AW; Cai J; Zhao XL; Xu AM; Fu HQ; Nian H; Zhang SH
J Clin Pathol; 2009 Nov; 62(11):1003-8. PubMed ID: 19861558
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
